Glenmark Pharmaceuticals

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue3,4733,4193,2683,2916,248
Expenses3,0012,9622,8872,8723,895
EBITDA641.33631.36572.72606.972,560
EBIT521.05508.6274.68153.811,034
Profit Before Tax472.58456.337.9795.58967.40
Net Profit354.49348.034.3846.97610.43
Financial Ratios
Operating Profit Margin18.86%19.12%6.21%9.27%19.57%
Net Profit Margin10.42%10.54%11.50%8.52%25.57%
Earning Per Share (Diluted)12.5512.330.161.6621.62
Dividends Per Share0.000.000.000.000.00